Edition:
United Kingdom

Perrigo Confirms Patent Challenge For Generic Version Of Nascobal


Tuesday, 5 Mar 2019 

March 5 (Reuters) - Perrigo Company PLC ::PERRIGO CONFIRMS PATENT CHALLENGE FOR GENERIC VERSION OF NASCOBAL.PERRIGO COMPANY PLC - ENDO PHARMA INITIATED PATENT LITIGATION REGARDING PERRIGO'S PARAGRAPH IV ABBREVIATED NDP FOR CYANOCOBALAMIN NASAL SPRAY 500MCG.